Clinical trial
Effect of Anti-IgE in Non-Allergic Asthma
NCT00162773 · Johns Hopkins University, Other · Terminated
Key facts
| NCT number | NCT00162773 |
|---|---|
| Title | Effect of Anti-IgE in Non-Allergic Asthma |
| Official title | Effect of Anti-IgE in Non-Allergic Asthma |
| Lead sponsor | Johns Hopkins University, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug, Other |
| Interventions | omalizumab, Placebo |
| Enrollment | 29 |
| Start date | Apr 1, 2005 |
| Primary completion | Sep 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Sep 13, 2005 |
| Last update posted | Aug 28, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: